Comparison of Thrombelastography with Common Coagulation Tests

Summary

Thrombelastography, although proven as a useful research tool has not been evaluated for its clinical utility against common coagulation laboratory tests. In this study we compare the thrombelastographic measurements with six common tests (the hematocrit, platelet count, fibrinogen, prothrombin time, activated thromboplastin time and fibrin split products). For such comparisons, two samples of subjects were selected, 141 normal volunteers and 121 patients with cancer. The data was subjected to various statistical techniques such as correlation, ANOVA, canonical and discriminant analysis to measure the extent of the correlations between the two sets of variables and their relative strength to detect blood clotting abnormalities. The results indicate that, although there is a strong relationship between the thrombelastographic variables and these common laboratory tests, the thrombelastographic variables contain additional information on the hemostatic process.

Keywords

Thrombelastography - Hematocrit - Platelets - Fibrinogen - Fibrin split products - P.T - A.P.T.T

• References

• 1 Howland WS, Castro EB, Fortner JB, Gould P. Hypercoagulability, thrombelastographic monitoring during extensive hepatic surgery. Arch Surg 1974; 108: 605-608
• 2 Raby C. Control of heparin therapy by thrombelastography. pp 211-218 In Kakkar VV, Thomas DP. ed Heparin: chemistry and clinical usage. Academic Press; London, England: 1976
• 3 Raby C. Heparinotherapie controlee. Presse, Med 1976; 74: 1526
• 4 Hume M. The relation of “hypercoagulability” to thrombosis. Surg Sri 1966; 2 (02) 133-158
• 5 Collins GJ, Ahr DJ, Rich NM, Anderson CA. Detection and management of hypercoagulability. Am J Surg 1976; 132: 767-770
• 6 De Nicola P. Thrombelastography. Springfield, III, Charles C Thomas. 1957
• 7 Merskey C. Pathogenesis and treatment of altered blood coagulability in patients with malignant tumors. Ann NY Acad Sri 1974; 230: 289-296
• 8 Caprini JA, Zuckerman L, Cohen E, Vagher JP, Lipp V. The identification of accelerated coagulability. Thromb Res 1976; 9: 167-180
• 9 Cohen E, Caprini JA, Zuckerman L, Vagher P, Robinson B. Evaluation of three methods used to identify accelerated coagulability. Thromb Res 1977; 10: 587-604
• 10 Eliot RL, von Kaulla K, Blount SG. Thrombelastographic studies with a twenty-four hour schedule for subcutaneous heparin. Circulation 1961; 24: 1206-1214
• 11 Morrison FD. Multivariate statistical methods. McGraw Hill. 1976
• 12 Dixon WG, Brown BM. Biomedical computer programs P-series. University of California Press; 1979
• 13 von Kaulla KN. Continuous automatic recording of fibrin formation and fibrinolysis: A valuable tool for coagulation research. J Lab Clin Med 1957; 49: 304-312
• 14 De Nicola P, Mazzetti GM. Evaluation of thrombelastography. Am J Clin Pathol 1955; 25: 447-452
• 15 Astrup T, Egablad K. Thrombelastographic patterns produced by fibrinolytic agents incorporated in fibrin. Am J Physiol 1965; 209: 84-94
• 16 Ramstack JM, Zuckerman L, Mockros LF, Caprini JA, Vagher JP. Effect of platelet count and hematocrit on the coagulability of heparinized blood. Res Comm Chem Pathol Pharm 1978; 21: 327-342
• 17 Gollub S, Schaefer C. Structural alteration in canine fibrin produced by celloid plasma expanders. Surg Gynecol Obstet 1968; 783-793
• 18 Bick RL. Alterations of hemostasis associated with malignancy: Etiology, pathology, diagnosis and management. Thromb Haemostas 1978; 5: 1-26
• 19 Stewart GJ. The role of hypercoagulability in thrombosis. Br J Haematol 1978; 40: 359-362
• 20 Hathaway WE, Hays T. Hypercoagulability in childhood cancer. J Pediatr Surg 1975; 10 (06) 893-899
• 21 Amundsen MA, Spittell JA, Thompson JH, Owen CA. Hypercoagulability associated with malignant disease and with the postoperative state. Ann Int Med 1963; 58 (04) 608-616
• 22 Nye SW, Graham JB, Brinkhouse KM. The partial thromboplastin time as screening test for detection of latent bleeders. Am J Med Sri 1962; 243: 279
• 23 Quick AJ. The prothrombin time in hemophilia and in obstructive jaundice. J Biol Chem 1935; 109: 73
• 24 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogen. Acta Haematol 1957; 17: 237-246
• 25 Miale JB. Laboratory medicine. Haematology C V Mosley Co; St Louis, Mo: 1977
• 26 Sigma Technical Bulletin No 850, Fibrinogen/fibrin degradation products in serum. 05/1977
• 27 Hartert H. Klinische Blutgerinnungsstudien mit der Thrombelasto-graphie. Physiologische und methodische Grundlagen der Thrombela-stographie Dtsch Arch Klin Med 1952; 199: 234-292
• 28 Hartert H. Thrombelastography. Thrombosis and bleeding disorders: Methods and theory. Bang, Beller, Deutsch, Mammen 70-76 Stuttgart, New York, London: 1970
• 29 Zuckerman L, Ramstack JM, Vagher JP, Caprini JA, Mockros LF. Neutralization of heparin by cellular blood elements. Thromb Res 1975; 7: 149-159
• 30 Goodnight SH. Bleeding and intravascular clotting in malignancy: A review. Ann NY Acad Sri 1974; 230: 271-285